ArticleMolecular psychiatry2017

Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits.

S A Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.